Zosurabalpin could be the first drug in five decades capable of addressing difficult-to-treat Acinetobacter or any other Gram-negative bacteria, which disproportionately impact patients in hospital, causing infections such as pneumonia and sepsis.

Latest Video
New Stories
-
Priceline Pharmacy launches annual event with national menopause project
May 28, 2025 - - Latest News -
Anne Ruston welcomes her reappointment to health and the addition of NDIS
May 28, 2025 - - Latest News -
Pharmacy Guild says Healthscope collapse provides 'stark warning'
May 28, 2025 - - Latest News -
Across-the-board PBS levy would simply be a tax on the listing and pricing process
May 28, 2025 - - Latest News -
Cartherics to present at the 2025 BIO International convention
May 28, 2025 - -
Sussan Ley confirms the reappointment of Anne Ruston to health
May 28, 2025 - - Latest News -
How can you not be sceptical about a rigged one-sided process?
May 27, 2025 - - Latest News